Department of Chemistry
Analysis of Circulating Tumor Cells Laboratory
English » Μolecular Analyses » Circulating tumor DNA (ctDNA) » EGFR mutations detection in lung cancer patients
EGFR mutations detection in lung cancer patients
- Gene: EGFR
- Methodology: real-time PCR
- Instrumentation: Cobas z 480 (4800 V2) (IVD)
- Analytical characteristics: exceptional analytical sensitivity and specificity
- Requested sample: 6mL peripheral blood (EDTA)
The cobas® EGFR Mutation Test v.2
The only FDA-approved IVD for EGFR mutation detection in non-small cell lung cancer for plasma samples for first line therapy decisions